SHL Telemedicine Ltd. Reports Half-Year 2024 Financial Results

Ticker: SHMLF · Form: 6-K · Filed: Sep 26, 2024 · CIK: 1166834

Shl Telemedicine Ltd 6-K Filing Summary
FieldDetail
CompanyShl Telemedicine Ltd (SHMLF)
Form Type6-K
Filed DateSep 26, 2024
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: financial-results, 6-K, reporting

TL;DR

SHL Telemedicine dropped its H1 2024 results on 9/26 - check the filings for details.

AI Summary

SHL Telemedicine Ltd. filed a Form 6-K on September 26, 2024, reporting its financial results for the half-year ended June 30, 2024. The filing includes a press release, investor presentation, and financial report, which are incorporated by reference. The company is a foreign private issuer and files under the 1934 Securities Exchange Act.

Why It Matters

This filing provides investors with updated financial performance data for SHL Telemedicine Ltd., crucial for assessing the company's health and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial results filing and does not indicate any immediate or significant new risks.

Key Players & Entities

  • SHL Telemedicine Ltd. (company) — Registrant
  • September 26, 2024 (date) — Filing date and press release date
  • June 30, 2024 (date) — End of reporting period

FAQ

What specific financial results are detailed in the furnished exhibits?

The filing states that Exhibits 99.1, 99.2, and 99.3 contain a press release, investor presentation, and report with respect to the company's half-year 2024 financial results.

What is the reporting period for this 6-K filing?

The conformed period of report is for the half-year ended June 30, 2024.

What form does SHL Telemedicine Ltd. typically file its annual reports under?

SHL Telemedicine Ltd. indicates it files annual reports under Form 20-F.

What is the principal executive office address for SHL Telemedicine Ltd.?

The principal executive offices are located at 90 Yigal Alon Street, Tel Aviv 67891, Israel.

When was this Form 6-K filed with the SEC?

This Form 6-K was filed on September 26, 2024.

Filing Stats: 426 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2024-09-26 08:36:19

Filing Documents

From the Filing

SHL TELEMEDICINE LTD - 1166834 - 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-41641 SHL TELEMEDICINE LTD . (Translation of registrant's name into English) 90 Yigal Alon Street Tel Aviv 67891, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXPLANATORY NOTE On September 26, 2024, SHL Telemedicine Ltd. (the " Company ") issued a press release, an investor presentation and a report with respect to its half-year 2024 financial results, copies of which are furnished herewith as Exhibits 99.1, 99.2 and 99.3, respectively, and which are incorporated by reference herein. The press release, investor presentation and report all contain forward-looking statements and include cautionary statements identifying important factors that could cause actual results to differ materially from those in the forward-looking statements. On September 26, 2024, the Company also published unaudited interim condensed consolidated financial statements as of and for the six months ended June 30, 2024, a copy of which is furnished herewith as Exhibit 99.4 and which is incorporated by reference herein. The financial statements are formatted in Inline eXtensible Business Reporting Language ("iXBRL") as Exhibit 101 in accordance with Rule 405 of Regulation S-T and paragraph C.(6)(a)(ii) of the General Instructions to Form 6-K. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546) . Exhibit Description 99.1 Press release, dated September 26, 2024, with respect to half-year 2024 financial results. 99.2 Investor Presentation issued on September 26, 2024, with respect to half-year 2024 financial results. 99.3 Report with respect to half-year 2024 financial results. 99.4 Unaudited interim condensed consolidated financial statements as of and for the six months ended June 30, 2024. 101.INS Inline XBRL Instance Document. 101.SCH Inline XBRL Taxonomy Extension Schema Document. 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase. 101.LAB Inline XBRL Taxonomy Extension Label Linkbase. 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL Telemedicine Ltd. By: /s/ Amir Hai Amir Hai Chief Financial Officer September 26, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.